Tag Archives: U.S. FDA

FDA) has issued Establishment Inspection Report (EIR) to subsidiary Aurolife Pharma’s plant in North

Aurobindo Pharma on Monday (August 17, 2026) said the U.S. Food and Drug Administration (U.S. [...]